Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Meropenem reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Meropenem

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,000Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8Meropen

    02 2Merrem/Meronem

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Meropen

    Meropenem Hydrate

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Meropen

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Dainippon Sumitomo

    Meropenem Hydrate

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 287

    2019 Revenue in Millions : 213

    Growth (%) : 35

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Meropen

    Meropenem Hydrate

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Meropen

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Dainippon Sumitomo

    Meropenem Hydrate

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 295

    2020 Revenue in Millions : 287

    Growth (%) : 17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Meropen

    Meropenem Hydrate

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Meropen

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Dainippon Sumitomo

    Meropenem Hydrate

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 301

    2021 Revenue in Millions : 295

    Growth (%) : 2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Meropen

    Meropenem Hydrate

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Meropen

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Dainippon Sumitomo

    Meropenem Hydrate

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 174

    2022 Revenue in Millions : 323

    Growth (%) : -39

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Merrem/Meronem

    Meropenem

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Merrem/Meronem

    United Kingdom
    arrow
    AAPS 2024
    Not Confirmed

    AstraZeneca

    Meropenem

    Main Therapeutic Indication : Neuroscience and Mental Health

    Currency : USD

    2015 Revenue in Millions : 253

    2014 Revenue in Millions : 0

    Growth (%) : -100%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Merrem/Meronem

    Meropenem

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Merrem/Meronem

    United Kingdom
    arrow
    AAPS 2024
    Not Confirmed

    AstraZeneca

    Meropenem

    Main Therapeutic Indication : Neuroscience and Mental Health

    Currency : USD

    2014 Revenue in Millions : -13.70%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Meropen

    Meropenem Hydrate

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Meropen

    Japan
    arrow
    AAPS 2024
    Not Confirmed

    Dainippon Sumitomo

    Meropenem Hydrate

    Main Therapeutic Indication : Anti-bacterial

    Currency : USD

    2016 Revenue in Millions : 245

    2015 Revenue in Millions : 256

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Meropen

    Meropenem Hydrate

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Meropen

    Japan
    arrow
    AAPS 2024
    Not Confirmed

    Dainippon Sumitomo

    Meropenem Hydrate

    Main Therapeutic Indication : Anti-bacterial

    Currency : USD

    2017 Revenue in Millions : 290

    2016 Revenue in Millions : 258

    Growth (%) : 12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Meropen

    Meropenem Hydrate

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Meropen

    Japan
    arrow
    AAPS 2024
    Not Confirmed

    Dainippon Sumitomo

    Meropenem Hydrate

    Main Therapeutic Indication : Anti-Bacterial

    Currency : USD

    2018 Revenue in Millions : 131

    2017 Revenue in Millions : 30

    Growth (%) : 339%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Meropen

    Meropenem Hydrate

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Meropen

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Dainippon Sumitomo

    Meropenem Hydrate

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2019 Revenue in Millions : 206

    2018 Revenue in Millions : 135

    Growth (%) : 52

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF